Company Directory - Verve Therapeutics, Inc.
Company Details - Verve Therapeutics, Inc.
Verve Therapeutics, Inc.
WebsiteVerve Therapeutics, Inc. is a biotechnology company focused on developing gene editing therapies for cardiovascular diseases. The company aims to provide innovative solutions that can address the underlying genetic causes of conditions such as atherosclerosis, and its mission is to transform how such diseases are treated through its proprietary base-editing platform.
CCI Score
CCI Score: Verve Therapeutics, Inc.
0.00
Latest Event
Take Action
So what can you do? Support Verve by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
PENDING
Verve Therapeutics, Inc. is currently rated as a Pending.
Alternatives
Dallas, United States
44.45
Zug, Switzerland
22.95
Beijing, China
0.00
_0.png?VersionId=E54j6B2ssY0mos4wxJcXCOh7Hall1IAR)
New York, United States
-1.65
Cambridge, United States
-13.08
Fremont, United States
-42.48
Corporation
63.97
Corporation
11.46
Corporation
0.00
Corporation
0.00
Industries
- 325414
- Biological Product (except Diagnostic) Manufacturing
- 541715
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 621511
- Medical Laboratories